The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://smallcapnetwork.co.uk/2024-awards/
"ESG Company of the Year
The winner will have demonstrated environmental sustainability practices, social responsibility initiatives within communities served by the company, governance transparency and accountability measures implemented by the company, ESG reporting quality and standards adherence, employee diversity and inclusion efforts, and overall commitment to sustainable business practices."
That’s my objective 👍
Rinse and repeat
Share price gradually been heading towards a level where some interest will be sparked by the bottom feeders again .
Just a few weeks to go to the earnings report. With much of the approval process ratified and sales agreements in place. I'm looking forward to seeing the green shoots we've all been hoping for.
Let's hope 2025 latest
0riginally 10 year plan was up in 2021 but I invested a large chunk in 2015 - so target is now 2025
Https://www.edenresearch.com/investors/reports_and_presentations
When is your 10 years up?
Long-term shareholder: I've seen a rollercoaster over the years as Eden announces each approval. The current SP is much lower than I'd hoped at this stage. However, my ten year plan was to see a dividend. I believe that’s on target.
"It is a simple thing; believe in the team a running the company or sell. "
Well the game here is to have sold out just before a money raise & wait for the share price to skirt 4p before dipping back in
Sit back watching the money get spent and then wait for a blizzard of excting new licences and territories and trade deals to spin the sp in order for them to raise some new cash.
What you can guarantee is that the weather in 2024 will either be too hot ,cold. wet or dry
Plus a glossy annual report which is a work of art .
Having checked out various comments and statements made on the bulletin board of A D V F N, do be aware that one or two almost state their opinions as if they are public relations for Eden Research and they are not. This has been going on for some time from what I have read.
People should read and listen to what the COMPANY write and put out and definitely not believe random posters on a bulletin board who seem think they know everything. Some believe these posters and that is dangerous. One posts with some comments which are common sense but also assumes a level of knowledge which he shows is lacking. The poster repeatedly misunderstands what the company is saying and he purports to be an expert. Actually, his seeming conviction is very misleading. For instance, there are comments about how Eden Research would value the company. Cavendish have given a guide price and that's obviously as much as the company can say.
I believe that this poster does not understand procedures etc and I do not think that he has any relevant experience. If you keep repeating something, it definitely does not make it true and posting on a bulletin board about how a company should be doing something is quite ridiculous.
It is a simple thing; believe in the team running the company or sell. The team created all the potential and has built up the business as it is today so we must let them get on while they continue to build for the future.
Https://www.sipcamagrousa.com/news/introduction-to-mevalone-video
Https://m.youtube.com/watch?v=Hocl6C-Kr_k&pp=ygUSU2lwY2FtIGliZXJpYSBBUkFX
Thanks for the link/vídeo Andonwards. Very good! And success to us, Eden shareholders! :)
Https://www.sipcamagrousa.com/news/sipcam-agro-usa-announces-commercial-launch-of-mevalone/
By Igor Teslenko ending:
"The Transformational Power of Innovation
A common theme throughout the three events was the importance of innovation to ensure a smooth transition and the immense opportunities that innovation has to offer. The EU must mobilize its innovative potential if the sustainability transformation is to be fair and effective. This means an enabling policy framework so that the EU is not left behind on the journey to more sustainable agriculture.
At Corteva, we are committed to playing our part. We are working to create solutions to some of agriculture’s most pressing challenges through our capacity to innovate, reducing greenhouse gas emissions in our operations, and promoting biodiversity. Last year, we confirmed our new sustainability and R&D commitments: Every new solution from our pipeline must meet our sustainability criteria by 2025. Along with this commitment, our company is increasing its R&D investment to eight percent of annual net sales by 2025.
Agriculture at a Crossroads
We are at a crucial turning point with the European elections coming up this year, the strategic dialogue on agriculture due to be launched, the strategic autonomy initiative, and the latest policy initiatives.
The world and Europe are not as they were when the Green Deal was launched. While the ambition and intent of the green transition remains, the tools to achieve the solutions need to be reassessed in the context of the changing geopolitical landscape and fragile food security.
As always, we operate in a spirit of openness and collaboration, ready to work with all stakeholders to create a greener, food-secure future that benefits us all. I am proud of Corteva's role in hosting these collaborative circular conversations and see its conclusion, in many ways, as only the beginning. The next steps are to ensure this dialogue reaches member state levels.
Behind the success of this series is its participants, and we were fortunate to have exceptional panelists, audience members, and partners, the FT Live. Thank you for your time, expertise, and energy, which made this series a resounding success. Together, we are better equipped to rise to the challenges we face as we transition. Together, we are growing for good"
Growing For Good Financial Times + Corteva Agriscience
Corteva's EMEA President, Igor Teslenko will be attending this event on 23rd January 2024.
https://growingforgood.live.ft.com/
"Growing for Good: Closing Ceremony | Strategies to Transition to a Sustainable Food System and Deliver EU’s Climate Goals
This high-level exclusive keynote discussion and knowledge sharing opportunity forms the fourth and final part of the Growing for Good series. This event, which will be conducted in the format of a conversation, is designed to present key takeaways and ideas directly to the European Commission."
For information
https://www.corteva.com/products-and-services/seed-applied-technologies.html
What do people consider to be the latest market guidance / broker consensus for revenues in FY 2013? Around the half-year I saw the figure of 2.6m euros talked about for full year sales but more recently Cavendish were quoting 4.9m. IMO 5m euros must be close to break even.
Does anyone have a view on this they would like to share...... ?
Https://www.sipcamagrousa.com/agriculture-products/fungicides/mevalone-fungicide/
Https://www.sgs.com/en/news/2023/10/safeguards-12623-eu-regulates-microplastics-under-reach
Effective dates:
Plant protection products, seed treated with such products and biocidal products
< 0.01%
October 17, 2031
Encapsulation of fragrances
< 0.01%
October 17, 2029
Lip, nail and make-up products, unless covered by item 2 or 6, or contain microbeads
< 0.01%
October 17, 2035
https://www.hibiscus-plc.co.uk/eu-adopts-restriction-of-intentionally-added-microplastics/
https://rethinkplasticalliance.eu/news/european-commision-finally-restricts-intentional-use-of-microplastics-in-first-concrete-victory-for-ecosystems-and-human-health/
https://reasonstobecheerful.world/microplastics-europe-ban-natural-alternatives/